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Medicinal plants play a key role in malaria control in Africa, especially in remote areas where health facilities are limited. In
order to assess their acclaimed potentials, eleven extracts were prepared from seven selected plants commonly used in Western
Cameroon,andtestedbothfortheirantiplasmodialactivityandcytotoxicity. TheantiplasmodialactivitywasassessedusingLactate
Dehydrogenase Assay(pLDH) andthe cytotoxicity estimatedonLLC-MK2monkeykidneyepithelial cells. Sevenextracts from ﬁve
diﬀerent plants were signiﬁcantlyactive, with very weak or no cytotoxicity. The Dacryodes edulis leaves showed the highest activity
(IC50 of 6.45µg/mL on 3D7 and 8.2µg/mL on DD2) followed by the leaves of Vernonia amygdalina (IC50 of 8.72 and 11.27µg/mL
on 3D7 and DD2 resp.) and roots of V. amygdalina (IC50 of 8.72µg/mL on 3D7), Coula edulis leaves (IC50 of 13.80µg/mL and
5.79µg/mL on 3D7 and DD2 resp.), Eucalyptus globulus leaves (IC50 of 16.80µg/mL and 26.45µg/mL on 3D7 and DD2) and
Cuviera longiﬂora stem bark (IC50 of 20.24µg/mL and 13.91µg/mL on 3D7 and DD2). These ﬁndings justify the use of ﬁve of the
seven plants in malaria treatment by traditional healers of Western Cameroon.
1.Introduction
Malaria is the world’s most important parasitic disease
especially when Plasmodium falciparum is the causative
agent. From the recent World Malaria Report, there were
an estimated 225 million malaria cases, with 800,000 deaths
among the 3 billion people at risk in 2009. About 91%
of total deaths occurred in Africa with pregnant women
and children under 5 years being the most aﬀected groups
of the populations [1]. Cameroon ﬁgures among the 18
countries bearing 90% of malaria deaths in Africa, with 71%
of its population living in high-transmission areas [2]. In
the western region of Cameroon, for example, malaria was
shown to be the most important cause of infant mortality
causing about 45% deaths and 54% hospitalizations for
children underﬁve [3]. In the absence of aneﬀectivevaccine,
the ﬁght against malaria relies mainly on chemotherapy
and vector control. The resistance of Plasmodium falciparum
to the commonly used antimalarial drugs including the
newly introduced Artemisinins has resulted in resurgence
in treatment failures [4, 5]. Hence, new highly eﬃcacious
and aﬀordable antimalarial agents are urgently needed. For
hundreds of years, plants have constituted the basis of
traditional medicine systems and natural productshave been
a good source for drug development. Some examples are
Quinine and Artemisinin that have been used successfully
against resistant strains of malaria parasites. In some rural
areas of Cameroon, antimalarial traditional medicines are
even preferred to pharmaceutical compound drugs, sug-
gesting that the herbal preparations used by traditional
healers contain useful active ingredients [6]. The oﬃce of
Traditional Medicine at the PublicHealth Ministry promotes
and coordinates Traditional Medicine Practice in Cameroon.
However many gaps still remain to fully exploit the potential
of herbal medicines as a solution to the malaria burden
and this demands combined eﬀorts from public sector,
research institutions, funding bodies and pharmaceutical
groups, traditional healers, and the populations themselves.2 Malaria Research and Treatment
A previous review by Titanji et al. [5] showed that over
200 diﬀerent plant species have been identiﬁed in Cameroon
for their use as antimalarial in folk medicine. But only
26 species had undergone full investigation leading to
isolation and testing of pure products, up to 137 species
remaining untested [7]. Therefore, there is a need to pursue
investigations on the plants so far identiﬁed in order to
foster and standardize their use either as herbal medicines or
sources of new drug candidate molecules. The present study
thus aims at screening the crude extracts from seven widely
used plants, namely, methylene chloride/methanol (1:1)
extractsofCuvieralongiﬂora,DacryodesedulisandEucalyptus
globules leaves, Vernonia amygdalina leaves and roots, the
hexane and methylene chloride extracts of Kotschya speciosa
aerial part and the methylene chloride extracts of the whole
plant, the methanol extract of Coula edulis stem bark, the
methylene chloride/methanol (1:1),and methylene chloride
extracts of Vismia guinensis stem bark, for their postulated
antiplasmodial activity.
2.Materialsand Methods
2.1. Collection of Plants Materials. All the plant parts were
collected in Batcham (Bamboutos division, Western Region
Cameroon)inApril2008.Thesampleidentiﬁcationwascon-
ﬁrmed at the Cameroon National Herbarium by matching
them with existing Voucher specimens deposited at the same
institution in Yaounde.
2.2. Preparation of Crude Extracts. The air dried and pow-
deredplant material (3.5Kgofeach) was macerated forthree
days at room temperature separately and concurrently in
10L of each of the following solvents: a methylene chlo-
ride/methanol (1:1) mixture, methylene chloride, hexane
and methanol. The mixture was ﬁltered with Whatman
paper, thenconcentrated to dryness toviscous residues using
a Rotavapor system (B¨ UCHI Labortechnik AG, Switzerland)
[5]. The crude extracts prepared were stored at 4◦Cf o r
further use.
2.3. Parasite Strains. The 3D7 (MRA-102) strain was
obtained from MR4 (Manassas, VA, USA) and maintained
in continuous culturewith backup stored in liquid nitrogen.
The DD2 strain was kindly donated to our research team
byProf.AlexRowefromC.I.I.EofEdinburghUniversity,UK.
2.4. Plasmodium Falciparum Culture and Maintenance. P.
falciparum were grown and maintained in culture using the
method of Trager and Jensen with some modiﬁcation [8].
All the chemicals except Albumax II (Gibco; Invitrogen,
USA) were ordered from Sigma-Aldrich Inc (Germany).
Cultures consisted of a 4% hematocrit suspension of O+
human erythrocytes in RPMI 1640 medium supplemented
with Gentamicin solution at 0.01mg/mL, 25mM HEPES
buﬀer, 25mM NaHCO3, and 1% Albumax II. Cultures were
fed with a gas mixture containing 5% CO2 and incubated
at 37◦C. The estimation of the parasitaemia as well as
parasite visualisation before incubation was done using both
Fluorescence (Acridine Orange) and normal light (Giemsa
stain) microscopes.
2.5. Determination of In Vitro Antiplasmodial Activity. Drug
sensitivity assay was carried out in 96-well microtitration
plates as described by Desjardins et al. [9]w i t hs o m e
modiﬁcations [10]. The crude extracts were dissolved in
dimethyl sulfoxide (200µL) and prediluted with culture
medium to make a ﬁnal concentration of 1000µg/mL. All
stock solutions were sterilized by passing them through a
0.2µms y r i n g eﬁ l t e ra n ds t o r e da t−20◦C until required.
Similarly chloroquine stock (2µg/mL) used as positive
control, was prepared from liquid Chloroquine phosphate
(Greenﬁeld Pharmaceutical LTD, Jiang Su, China).
Dose-response assay was carried out to obtain the 50%
inhibitory concentration (IC50) of the individual drugs.
Ring stage infected erythrocytes (100µLp e rw e l lw i t h
2% hematocrit and 1% parasitaemia) were incubated in
triplicate with twofold serial dilution of each drug for 48
hours. Each experiment was performed in duplicate separate
experiment. Parasitaemia was measured using the parasite
lactate dehydrogenase (pLDH) assay [8].
2.6. Lactate Dehydrogenase (pLDH) Assay. While incubation
of parasites with products was going on, the two reagents
for detecting and measuring the LDH enzyme were prepared
[8]. The ﬁrst of these is the Malstat reagent, which was made
by dissolving 400µL of Triton X-100 in 80mL of deionised
water, adding L-lactate (4.00g), Tris buﬀer (1.32g), and
0.022g of 3-acetyl pyridine adenine dinucleotide (APAD),
adjusting the pH to 9 with hydrochloric acid, and bringing
t h ev o l u m eu pt o2 0 0m Lw i t hd e i o n i s e dw a t e r .T h es e c o n d
reagent is NBT/PES solution, and it was prepared by
dissolvingnitrobluetetrazoliumsalt(0.160g)andphenazine
ethosulfate (0.008g) in 100mL of deionized water. The
solution was stored in a foil-covered container and kept in
the refrigerator until required. All reagents for preparing the
Malstat reagent and NBT/PES solution were purchased from
Sigma-Aldrich Inc. When incubation was complete, plates
were harvested and subjected to three 20-minute freeze–
thaw cycles to release the cell content and resuspend the
culture. Thereafter, 100µL of Malstat reagent and 25µLo f
NBT/PES solution were added to each well of a new ﬂat-
bottomed 96-well microtiter plate in triplicate. Thereafter,
the culture in each well was mixed and 20µLo ft h ec u l t u r e
taken from each well and added to the corresponding well of
the Malstat plate, 25µL of NTB/PES were then added to each
well, thereby initiating the lactate dehydrogenase reaction.
Colour development of the LDH plate was monitored
colorimetrically at 650nm with the aid of a plate reader
(Emax-Molecular Devices Corporation, California, USA)
after an hour of incubation in the dark.
2.7. Analysis of Test Results from the LDH Assay. The LDH
assay generates optical density (OD) values at various
concentrations of the drug as raw data. OD values from
control wells represent the maximum amount of LDH
that is produced by parasites and OD values from blankMalaria Research and Treatment 3
wells represent background LDH activity. A 100% growth
value, which corresponds to maximum LDH activity, was
obtained by subtracting the mean OD value of blank wells
from that of control wells. Likewise, the growth value at
each concentration of the drug was obtained by adjusting
OD values from drug-treated wells for background LDH
activity (parasite-free red blood cells). These values were
then expressed as a percentage of the 100% growth value
and plotted against corresponding concentrations of the
drug using GraphPad Software (San Diego California USA,
http://www.graphpad.com/) to generate log dose-response
curves from which IC50 values were obtained. Each extract
were tested in triplicate. IC50 values were log transformed
a n de x p r e s s e da sg e o m e t r i cm e a nI C 50 and 95% conﬁdence
intervals for the geometric mean calculated for the repli-
cates. The OD values obtained were also used to verify
the diﬀerent IC50s and determine IC95 values using the
software HN-NonLin V1.1 (http://www.malaria.farch.net/).
The diﬀerent IC50s values obtained were then grouped and
their means calculated and compared among themselves
using Independent-Samples t-test.
2.8. Cytotoxicity Study of Extracts. The cytotoxicity of the
extracts and pure compounds was estimated against LLC-
MK2 (ATCC, USA) monkey kidney epithelial cells according
to the procedure previously described [11]w i t hs o m e
modiﬁcations. Cells were cultured in the same conditions as
P. falciparum. For the determination of the toxicity of the
extracts,cellsweredistributedin96-well platesat20,000cells
per well in 100µL culture medium. Cells were allowed to
attach for 24 hours. The medium was removed completely
the following day, and 100µL of fresh medium added to
all the wells. Then, 100µL of crude extract (1000µg/mL)
were added in triplicate in row H and twofold serial dilution
made upward ending at row B, and 100µL of medium added
to all the wells to have concentration range of 250–3.90,
cells at raw A serving as control without drug. The plates
were incubated for 72 hours at 37◦Ci n5 %C O 2 air. Cells
concentration and viability in the presence of extract or pure
compounds were compared with that of control cultures
without extracts. The deﬁnition of the cytotoxicity used
[11]w a sC C 50 <1.0µg/ml (high cytotoxicity), CC50 1.0–
10.0µg/mL (moderate), CC50 10.0–30.0µg/mL (mild), and
CC50 >30µg/mL (nontoxic). The selectivity index deﬁned
as SI=CC50/IC50 was also calculated.
3.Results
Table 1 summarizes some characteristics ofthe plant extracts
tested in the present study. It can be seen that E. globulus
leaves had the highest extraction yield, followed by V.
amygdalina leaves, whereas K. speciosa in hexane recorded
the lowest yield.
Table 2 presents the results of antiplasmodial activity
and cytotoxicity of the ten extracts tested together with the
activity of Chloroquine phosphate. The values of IC50 range
from 8.72 to 64.30µg/mL. Sevenofthe elevenextracts exhib-
ited signiﬁcant antiplasmodial activity (IC50 < 50µg/mL) on
both 3D7 and DD2 strains of malaria parasite. These active
extracts were prepared from ﬁve diﬀerent plant species:
D. edulis, C. longiﬂora, E. globulus, K. speciosa,a n dV.
amygdalina and C. edulis. The most active extracts were
from D. edulis followed by V. amygdalina with IC50 values
below 10µg/mL on 3D7 and the lowest IC50 values on
the Chloroquine-resistant strain. No sign of cytotoxicity
was observed with extracts from D. edulis, V. guinensis, V.
amygdalina,a n dm e t h y l e n ec h l o r i d ee x t r a c t so fK. speciosa,
whereas extracts from C. edulis, E. globulus,a n dC. longiﬂora
showed a very low cytotoxicity on LLC/MK2 epithelial cells.
4.Discussion
Eleven crude extracts prepared from seven diﬀerent plant
species from Western Cameroon were screened in vitro for
their antiplasmodial activity and cytotoxicity.
E. globulusrecorded the highest extraction yield (2.02%),
followed by V. amygdalina root (1.85%), whereas aerial
part of Kotschya speciosa (KSH) had the lowest yield. In
general, extraction yields were the highest with Methylene
Chloride/Methanol (1:1) mixture. This may be because
the solvent system extracts both polar and nonpolar con-
stituents, unlike the ones used in extracting the other plants
which were either polar or nonpolar solvents.
The antiplasmodial activity of Vernonia amygdalina and
Eucalyptus globulus was previously reported [5]. IC50 values
range from 6.45 to 65.29µg/mL, with three extracts (DEL,
VAL and VAR) exhibiting high activity (1<IC50 ≤10µg/mL),
four with moderate activity on both chloroquine sensible
and multiresistant strains of P. falciparum (10 < IC50 ≤
25µg/mL), and one (VGE) with weak activity (25 < IC50 ≤
50µg/mL), whereas three of them (KS, KSR and VGS)
showed very weak antiplasmodial activity (50 < IC50 ≤
100µg/mL).
D. edulis exhibited the highest activity, followed by V.
amygdalina, Coula edulis,a n dEucalyptus globulus. D. edulis
hasalonghistoryofuseinfolkmedicine.Itisamultipurpose
plant in African folk medicine, as its various parts are used
to treat several diseases. Itis used in traditional medicine as a
remedy for parasitic skin diseases, jigger, mouthwash, tonsil-
litis, sickle cell, and malaria [12, 13]. Phytochemical analysis
of the leaves revealed the presence of phenolic compounds
[14], and several compounds from this class have previously
been shown as having antiplasmodial activity [15]. Their
presence may, therefore, explain the antiplasmodial activity
observed. In Western Cameroon, the leaves of D. edulis are
boiled with those of Cymbopogon citratus and Mangifera
indica in water to form a concoction against malaria, but
information concerning in vitro antiplasmodial of the leaves
extracts hasnot beenreported earlier. Ourﬁndings justifying
the use of D. edulis as antimalarial could, therefore, be used
as background knowledge for further studies of the plant as
potential source for antimalarial leads.
The V. amygdalina leaves are commonly used to treat
malaria and other ailments [4]. Phytochemical screening of
V. amygdalina revealed the presence of alkaloids, glycosides,
saponins, tanins, ﬂavonoids, proteins, and carbohydrates4 Malaria Research and Treatment
Table 1: Plant parts used and their extraction yields.
No. Scientiﬁc name
(Family) Local name (Locality) Part used Solvent Extraction yield (% w/w)
1 Cuviera longiﬂora
(Rubiaceae) ND Leaves CH2Cl2/MeOH (1:1) 1.40
2 Dacryodes edulis
(Burseraceae) Zo’o (Batcham) Leaves CH2Cl2/MeOH (1:1) 1.68
3 Eucalyptus globules
(Myrtaceae) Klatusse (Batcham) Leaves CH2Cl2/MeOH (1:1) 2.02
4
Whole plan CH2Cl2 0.86
Kotschya speciosa
(Leguminoceae) ND Aerial part Hexane 0.52
Aerial part CH2Cl2 0.64
5 Coula edulis
(Olacaceae) Walnut (Batcham) Stem bark MeOH 0.78
6 Vernonia amygdalina
(Asteraceae) Bitter leaf (Batcham) Leaves CH2Cl2 1.75
Root bark CH2Cl2 1.85
7 Vismia guinensis




CH2Cl2/MeOH (1:1): methylene chloride/methanol mixture (1:1); CH2Cl2: methylene chloride; MeOH: methanol; %w/w: percentage weight/Weight; ND:
not determined.
Table 2: Antiplasmodial activity and cytotoxicity of the tested products.
Scientiﬁc name
(Family) Part used (Code) IC50 on 3D7 (µg/mL) IC50 on DD2 (µg/mL) CC50 on LLC/MK2
(µg/mL)
SI on 3D7 (SI on
DD2)
Cuviera longiﬂora Leaves (CLL) 20.24±4.95 13.91±0.65 250 12.35 (17.91)
Dacryodes edulis
(Burseraceae) Leaves (DEL) 6.45±0.88 8.62±1.44 >1000 ND
Eucalyptus globulus Leaves (EGL) 16.80±8.35 26.45±3.32 208.33 12.40 (7.88)
Kotschya speciosa
Whole plant (KS) 48.29±4.46 108.89±17.21 >1000 ND
Aerial part (KSH) 22.61±10.34 ND 625 27.64
Aerial part (KSR) 64.30±12.76 59.30±8.32 >1000 ND
Coula edulis Stem bark (CE) 13.80±3.25 5.79±1.33 178.57 12.94 (30.84)
Vernonia amygdalina Leaves (VAL) 8.72±2.11 11.27±2.06 >1000 ND
Root bark (VAR) 9.01±1.11 ND >1000 ND
Vismia guinensis Stem bark (VGE) 43.42±2.76 4.735±3.54 >1000 ND
Stem bark (VGS) 65.29±7.58 62.5±12.45 >1000 ND
Chloroquine 0.10 0.95±0.01 — —
IC50: inhibition 50%, CC50: cytotoxic concentration 50%, each value represents the average and standard deviation obtained from 6 diﬀerent measurements;
ND: not determined.
[16]. Alkaloids are one of the most important classes of
natural products providing drugs since ancient times. The
outstanding example is quinine from Cinchona succirubra
(Rubiaceae) used for the treatment of malaria for more
than three centuries [17]. Equally, ﬂavonoids are shown to
inhibit the malaria parasite growth through the L-glutamine
pathwayalthoughtheirexactmechanism ofactionisyettobe
clariﬁed [18]. Severalplants oftheAsteraceae (Compositeae)
family have been revealed as good source for antimalarials,
the most famous one being Artemisia annua the Chinese
herbfrom which artemisinin (quinghaosu)wasisolated[19].
Equally, Lupeol was identiﬁed as a compound responsible
for the antimalarial activity of the Vernonia brasiliana leaves,
inhibiting the P. falciparum growth by 45% when tested
at 25µ/mL. The high activity observed from the present
investigation with both leaves and roots of V. amygdalina
which is a member of this family thus supports the use of
this plant for malaria by traditional healers.
Phytochemical screening of Coula edulis by Adebayo-
Tayo and Ajibesin [20] revealed the presence of alkaloids,
glycosides, saponins, tanins, ﬂavonoids, and terpenes [20].
C. edulis has been shown to exhibit a wide range of antimi-
crobial and antifungal activities but from the literature, the
antiplasmodial activity of this species has not previously
been reported. The presence of compounds like alkaloids,
saponins, ﬂavonoids, and glycosidesmay be the source of theMalaria Research and Treatment 5
antiplasmodial activity exhibited by this plant. Our ﬁndings,
therefore, corroborate the use of C. edulis as antimalarial in
Cameroonian folk medicine.
Eucalyptus globulus which is widely employed by tra-
ditional healers of Western Cameroon for malaria has
previously been studied for its postulated properties [4].
PreviousstudieshaverevealedE.globulustobea goodsource
of antimicrobial leads [21]. The leaves of Eucalyptus robusta
(another plant of the same genus) are used in China for
the treatment of dysentery, malaria, and bacterial diseases.
Three active compounds, Robustaol A, Robustadial A, and
Robustadial B, were isolated from the ethanol extract of the
leaves [22]. The present work on the crude extract from
leaves agree with these previous ﬁndings, justifying the wide
use of E. globulus as antimalarial by endogenous traditional
healers of Western Cameroon.
Cuviera longiﬂora is a medicinal plant commonly used
across the continent and out of Africa to treat various
ailments. No report on investigation of this plant for its
biological activity was found. The results obtained from our
study reveal that C. longiﬂora has antimalarial properties.
Further phytochemical screening may lead to identiﬁcation
of ingredients responsible for the observed antiplasmodial
activity of the plant.
All the tested extracts were found to be noncytotoxic or
withverylowtoxicityonLLC/MK2monkeykidneyepithelial
cells. This observation may be an indicator of their safety as
drugs for mammalian organisms. Some of the plants tested
in this study like V. amygdalina and D. edulis are widely used
in many African countries including Nigeria and Cameroon
for both therapeutic and nutritional purposes [23]. No part
of D. edulis is known to be toxic, except the presence of some
antinutrient factors such as oxalate, tannins, phytates, and
trypsin-inhibitors in the seeds [24, 25].
5.Conclusions
From this study, it was observed that Dacryodes edulis,
Vernonia amygdalina, Coula edulis, Eucalyptus globules,a n d
Cuviera longiﬂora possess signiﬁcant antiplasmodial activi-
ties. Both leaves and roots of V. amygdalina showed high
antiplasmodial activity with no cytotoxicity. The results
obtained justify the use of these plants by traditional
healers of Western Cameroon. Further investigations on
some of these plants, especially including bioassay-guided
fractionation of extracts from D. edulis, V. amygdalina,a n d
Coula edulis, are likely to yield new antimalarial drug leads.
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